PATENT CLAIM ANALYSIS

Application Number: 15770444
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "560000"]

Abstract:
The invention relates to a composition comprising) (i) one or more ω-3 fatty acids selected from the group consisting of DHA, DPA and EPA and (ii) one or more pyrimidine derivatives selected from the group consisting of uridine sources and cytidine sources for use in decreasing or normalizing the phenyl alanine level in the blood of a PKU patient or for use in dietary management of phenylalanine levels in the blood of a PKU patient.

Claim (Index 17):
The nutritional composition according to  claim 15 , wherein the composition comprises 1-15 wt. % lipid, 5-60 wt. % digestible carbohydrate and 1-14 wt. % protein, all based on the dry weight of the composition.

Metadata:
- Claim Count in Document: 16.0
- Percentile: 91.0
- Lexical Diversity: 1.67347
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14784838', '15770116', '13977162', '15102136', '14005098']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7952446525885337
- 35 USC 102 Novelty (BERT): 0.5545678200640869
- Combined Prediction Score: 0.771176969336089
- Mean Citation Score: 324.68270199999995
- Max Citation Score: 423.5979
- Similarity Product: 341.9068961608172

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test